Long-term management of atherothrombosis.
While clinical trials of specific antithrombotic agents can reduce the risk of vascular events in at-risk patients, understanding the results of these studies is key to optimizing benefit and minimizing risk.
Fox
Keith A
KA
Division of Medical and Radiological Sciences, University of Edinburgh, Edinburgh EH16 4SB.
D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000925:Anticoagulants / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000628:therapy*; D004338:Drug Combinations; D005544:Forecasting; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment; D013927:Thrombosis / Q000628:therapy*
D000925:Anticoagulants; D004338:Drug Combinations; D010975:Platelet Aggregation Inhibitors